Records containing: Influenza

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2021-09-02
  Understanding How the Initial Encounter With Influenza Virus Poises Children for Protective Immunity
• CLINICAL_TRIALS study record update · 2021-08-23
  Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)
• CLINICAL_TRIALS study record update · 2021-08-05
  Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle (pCHIMES)
• CLINICAL_TRIALS study record update · 2021-07-29
  A Double-blind, Randomized, Stratified and Controlled Clinical Trial With Split-virion and Whole-virion, Adjuvanted and Non-adjuvanted Influenza A/H1N1 Vaccines in Healthy Adults, Elders, Adolescents and Children
• CLINICAL_TRIALS study record update · 2021-07-26
  A Study to Evaluate the Safety and Immunogenicity of Concomitant Administration of the SARS-CoV-2 Inactivated Vaccine (Vero Cell) With Quadrivalent Influenza Vaccine in Adults Aged From 18 to 59 Years
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2021-07-14
  Apple Respiratory Study: A Prospective Study of Apple Watch-based Detection of Respiratory Viral Illness in Greater Seattle, WA
• CLINICAL_TRIALS study record update · 2021-05-28
  Patient Portal Reminder/Recall for Influenza Vaccination in the UCLA Health System- Pediatric Second Dose
• CLINICAL_TRIALS study record update · 2021-05-24
  Evaluation of the Effects of Age, Prior Exposure, and Previous Vaccination on the B Cell Response to Inactivated Influenza Vaccine in Healthy Adults and Children
• CLINICAL_TRIALS study record update · 2021-04-28
  A Controlled Human Infection Study of Influenza A/Bethesda/MM2/H1N1 Virus (A/California/04/2009/H1N1-like) in Healthy Subjects to Assess the Effect of Pre-Existing Immunity on Symptomatic Influenza Virus Infection
• CLINICAL_TRIALS study record update · 2021-04-28
  Intradermal Quadrivalent Influenza Vaccine With Topical Imiquimod in Elderly & Chronic Ill Subjects, a Double-Blind Randomized Controlled Trial
• CLINICAL_TRIALS study record update · 2021-04-26
  A Phase 2b Study to Determine the Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults Aged 18 Years and Over
• CLINICAL_TRIALS study record update · 2021-04-19
  A Phase II, Randomized, Controlled, Observer-Blind, Clinical Study to Evaluate the Humoral and Cell Mediated Immunity and Safety of Two Intramuscular Doses of MF59C.1-adjuvanted Subunit Influenza Vaccine or Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects Aged 6 to <36 Months
• CLINICAL_TRIALS study record update · 2021-03-23
  A Phase 2/3 Randomised, Observer-blind, Placebo-controlled, Multi-centre Study to Evaluate the Efficacy, Immunogenicity and Safety of the Adjuvanted SARS-CoV-2 Subunit Vaccine in Adults Aged 18 Years and Above
• CLINICAL_TRIALS study record update · 2021-03-23
  A Phase 3, Multicenter, Single-arm, Open-label, Study to Evaluate the Safety, Pharmacokinetics and Effectiveness of Intravenous Peramivir in Elderly Subjects With Acute Uncomplicated Influenza Infection and in Subjects With Acute Uncomplicated Influenza Infection at Higher Risk for Influenza Complications
• CLINICAL_TRIALS study record update · 2021-03-23
  A Phase 3, Randomized, Open Label, Active-controlled Study to Evaluate the Safety, Pharmacokinetics and Effectiveness of IV Peramivir Compared to Oral Oseltamivir in Pediatric Subjects With Acute Uncomplicated Influenza
• CLINICAL_TRIALS study record update · 2021-03-18
  Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model
• CLINICAL_TRIALS study record update · 2021-03-17
  A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza.
• CLINICAL_TRIALS study record update · 2021-03-16
  Procalcitonin Role in Influenza Patients With Regard to Morbidity, Mortality and Antibiotic Use
• CLINICAL_TRIALS study record update · 2021-03-09
  Comparison of Immunogenicity of Adjuvanted and Non-Adjuvanted Influenza Vaccination in a Long-Term Care Population
• CLINICAL_TRIALS study record update · 2021-03-09
  Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care
• CLINICAL_TRIALS study record update · 2021-02-25
  Clinical Study of the Safety of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) in Children With Asthma of Varying Levels of Severity
• CLINICAL_TRIALS study record update · 2021-02-21
  A Phase 1, Randomized, Controlled, Observer-blind Study to Assess the Reactogenicity, Safety, and Immunogenicity of a Live Attenuated Universal Influenza Vaccine (cH8/1N1 LAIV) Administered as a Single Priming Dose Followed Three Months Later by a Single Booster Dose of an Inactivated Universal Influenza Vaccine (cH5/1N1 IIV) (Adjuvanted With AS03A or Unadjuvanted) in 18 Through 39 Year-old Healthy Subjects, Contrasted With a Two Dose Schedule of an Inactivated Universal Influenza Vaccine (cH8/1N1 IIV + AS03A Followed Three Months Later by cH5/1N1 IIV + AS03A)
• CLINICAL_TRIALS study record update · 2021-02-15
  Evaluation of the Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok® Trivalent Recombinant Baculovirus-Expressed Hemagglutinin Influenza Vaccine in Healthy Adults Aged 18 to 49 Years
• CLINICAL_TRIALS study record update · 2021-02-04
  Evaluation of Moderate to Severe Influenza Disease in Children 6 Months to 8 Years in Colorado
• CLINICAL_TRIALS study record update · 2021-01-28
  A Single-center, Randomized, Double-blind, Placebo-controlled and Single-center, Randomized, Open, Double-crossed Food Impact Trial to Evaluate the Safety, Tolerability, Pharmacokineticof GP681 Tablets in Healthy Subjects